Vaxcyte Inc (PCVX) — Defensive Interval Ratio
Vaxcyte Inc (PCVX) has a Defensive Interval Ratio of 2226 days as of March 2026. Defensive assets of $1.48 Billion (cash $-, short-term investments $1.48 Billion, receivables $-) cover 2226 days of daily cash needs of $663.24K/day. See PCVX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Vaxcyte Inc Defensive Interval Ratio (2019–2025)
This chart shows how Vaxcyte Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 2226 days, meaning defensive assets of $1.48 Billion can fund 2226 days of operations without new revenue. See how leveraged is Vaxcyte Inc's balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Vaxcyte Inc (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Vaxcyte Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Vaxcyte Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2543 days | $1.43 Billion | $563.70K/day | $- | $1.39 Billion | ▼ -1050 days |
| 2024 | 3593 days | $1.38 Billion | $384.05K/day | $- | $1.36 Billion | ▲ +1869 days |
| 2023 | 1724 days | $686.38 Million | $398.19K/day | $- | $682.78 Million | ▲ +844 days |
| 2022 | 880 days | $97.72 Million | $111.03K/day | $- | $96.72 Million | ▼ -1385 days |
| 2021 | 2265 days | $178.19 Million | $78.67K/day | $- | $176.99 Million | ▲ +2263 days |
| 2020 | 2 days | $300.00K | $128.39K/day | $- | $0.00 | ▼ -4 days |
| 2019 | 7 days | $200.00K | $30.28K/day | $- | $- | — |